| Literature DB >> 31383266 |
David R Peaper1, Thomas Durant2, Sheldon Campbell3.
Abstract
We discuss the current practice of point-of-care diagnostics in infectious diseases as methods transition from antigen-based to molecular, and beyond simple molecular to the next generations of point-of-care testing methods. We evaluate the role of point-of-care at different sites of care and describe and evaluate trends likely to be driven by advances in molecular methodology, emerging biomarkers, and informatics. We describe strengths, weaknesses, opportunities, and threats to the development of point-of-care diagnostics in the near (1-10 years) and more distant (10-20 years) future. Published by Elsevier Inc.Entities:
Keywords: CLIA waived; Distributed microbiology; Microbiology; Point-of-care testing; Rapid testing
Year: 2019 PMID: 31383266 DOI: 10.1016/j.cll.2019.05.004
Source DB: PubMed Journal: Clin Lab Med ISSN: 0272-2712 Impact factor: 1.935